Literature DB >> 8220922

Re-evaluating the need for hospitalization following synovectomy using Yttrium-90 silicate.

R Jaworski1, R McLean, K Choong, R Smart, J Edmonds.   

Abstract

In 51 patients treated with Yttrium-90 (Y-90) synovectomy for rheumatoid (inflammatory) arthritis (IA) and OA of the knee we found that decreased retained knee activity (RKA) and increased extra-articular activity in lymph nodes and liver are more likely to be found in IA than OA and following bilateral knee injections. Joint inflammation, as assessed by radionuclide blood pool scan but not by SF white cell count, correlates with decreased RKA and increased activity in lymph nodes. Intra-articular steroid had no significant effect on retention or extra-articular uptake. Strict hospital immobilization improves RKA of Y-90 in IA but not in OA. Y-90 synovectomy in OA shows good RKA and low extra-articular uptake. We recommend strict immobilization following Y-90 synovectomy, particularly in IA patients and/or those with high joint blood flow.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220922     DOI: 10.1093/rheumatology/32.11.1012

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  3 in total

1.  Pretreatment macrophage infiltration of the synovium predicts the clinical effect of both radiation synovectomy and intra-articular glucocorticoids.

Authors:  Z N Jahangier; J W G Jacobs; M C Kraan; M J G Wenting; T J Smeets; J W J Bijlsma; F P J G Lafeber; P P Tak
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

2.  The intra-articular distribution of 90yttrium does not influence the clinical outcome of radiation synovectomy of the knee.

Authors:  Z N Jahangier; F M van der Zant; J W G Jacobs; H G Riedstra; G M M Gommans; J F Verzijlbergen; J W J Bijlsma; J W van Isselt
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 3.  [Radiosynoviorthesis].

Authors:  W Seidel
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.